Keld Fosgerau is a CEO, founder at Pephexia Therapeutics ApS. They is proficient in German, French and English. Colleagues describe them as "As a section manager at Rheoscience I had the pleasure working closely together with Keld Fosgerau for a two year period. I can highly recommend Keld as an excellent and very skilled scientist - especially in the different fields of in vivo pharmacology. At Rheoscience Keld was deeply involved in several aspects of company management, CRO marketing and development of new techniques. Keld was highly appreciated by all of his employees - and as a personal friend and hopeful future collaborator I can only give Keld my best recommendations." and "Keld is a very well-trained and skilled diabetes and obesity scientist with a broad knowledge of the basic science related to these important disease areas as well a good deal of experience with drug discovery within the same fields. Keld is super-dynamic and enthusiastic about everything he does and was a great asset (both scientifically and personally) in the target and drug discovery department at Rheoscience."